Short‐chain fatty acids profile in patients with SARS‐CoV‐2: A case‐control study

SARS‐CoV‐2, as a new pandemic disease, affected the world. Short‐chain fatty acids (SCFAs) such as acetic, propionic, and butyric acids are the main metabolites of human gut microbiota. The positive effects of SCFAs have been shown in infections caused by respiratory syncytial virus, adenovirus, influenza, and rhinovirus. Therefore, this study aimed to evaluate the concentration of SCFAs in patients with SARS‐CoV‐2 compared with the healthy group.

[1]  Zecheng Yang,et al.  Microbiota-derived short chain fatty acids: Their role and mechanisms in viral infections , 2023, Biomedicine & Pharmacotherapy.

[2]  M. Abdi,et al.  Microbiota metabolites in the female reproductive system: Focused on the short-chain fatty acids , 2023, Heliyon.

[3]  M. Ahangarzadeh Rezaee,et al.  Interaction Between Altered Gut Microbiota and Sepsis: A Hypothesis or an Authentic Fact? , 2022, Journal of intensive care medicine.

[4]  Ruiyan Zhang,et al.  Intestinal Microbiota-Derived Short Chain Fatty Acids in Host Health and Disease , 2022, Nutrients.

[5]  A. Custovic,et al.  Short-chain fatty acid acetate triggers antiviral response mediated by RIG-I in cells from infants with respiratory syncytial virus bronchiolitis , 2022, eBioMedicine.

[6]  A. Custovic,et al.  Acetate Triggers Antiviral Response Mediated by RIG-I in Cells from Infants with Respiratory Syncytial Virus Bronchiolitis , 2021, SSRN Electronic Journal.

[7]  S. Fujieda,et al.  Regulation of the Expression of SARS-CoV-2 Receptor Angiotensin-Converting Enzyme 2 in Nasal Mucosa , 2021, American journal of rhinology & allergy.

[8]  M. Mori,et al.  Microbiota-derived short-chain fatty acids do not interfere with SARS-CoV-2 infection of human colonic samples , 2021, Gut microbes.

[9]  Y. Hu,et al.  [Asymptomatic infection of COVID-19 and its challenge to epidemic prevention and control]. , 2020, Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi.

[10]  A. Tam,et al.  Gastrointestinal Manifestations of SARS-CoV-2 Infection and Virus Load in Fecal Samples From a Hong Kong Cohort: Systematic Review and Meta-analysis , 2020, Gastroenterology.

[11]  F. Messerli,et al.  Coronavirus Disease 2019 (COVID‐19): Do Angiotensin‐Converting Enzyme Inhibitors/Angiotensin Receptor Blockers Have a Biphasic Effect? , 2020, Journal of the American Heart Association.

[12]  Hannah Stower.  Virological assessment of SARS-CoV-2 , 2020, Nature Medicine.

[13]  K. Shi,et al.  Structural basis of receptor recognition by SARS-CoV-2 , 2020, Nature.

[14]  Kang Zhang,et al.  Characteristics of pediatric SARS-CoV-2 infection and potential evidence for persistent fecal viral shedding , 2020, Nature Medicine.

[15]  G. Herrler,et al.  SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor , 2020, Cell.

[16]  Amanda J. Pickard,et al.  Impact of gut colonization with butyrate-producing microbiota on respiratory viral infection following allo-HCT. , 2018, Blood.

[17]  S. Karna,et al.  Short-Chain Fatty Acids Alter Metabolic and Virulence Attributes of Borrelia burgdorferi , 2018, Infection and Immunity.

[18]  A. Peters,et al.  Short‐chain fatty acids induce tissue plasminogen activator in airway epithelial cells via GPR41&43 , 2018, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[19]  T. Roger,et al.  Impact of the microbial derived short chain fatty acid propionate on host susceptibility to bacterial and fungal infections in vivo , 2016, Scientific Reports.

[20]  Nagendra Singh,et al.  Benefits of short-chain fatty acids and their receptors in inflammation and carcinogenesis. , 2016, Pharmacology & therapeutics.

[21]  C. Mackay,et al.  Diet, metabolites, and "western-lifestyle" inflammatory diseases. , 2014, Immunity.

[22]  P. de Backer,et al.  Development of a HPLC-UV method for the quantitative determination of four short-chain fatty acids and lactic acid produced by intestinal bacteria during in vitro fermentation. , 2013, Journal of pharmaceutical and biomedical analysis.

[23]  R. Judd,et al.  Effects of high fat diet on GPR109A and GPR81 gene expression. , 2012, Biochemical and biophysical research communications.

[24]  J. Nosanchuk,et al.  Sodium butyrate inhibits pathogenic yeast growth and enhances the functions of macrophages. , 2011, The Journal of antimicrobial chemotherapy.

[25]  G. Macfarlane,et al.  Short chain fatty acids in human large intestine, portal, hepatic and venous blood. , 1987, Gut.

[26]  J. Luban.  SARS-CoV-2 , 2020 .

[27]  Y. Cong,et al.  Microbiota metabolite short chain fatty acids, GPCR, and inflammatory bowel diseases , 2016, Journal of Gastroenterology.